90 related articles for article (PubMed ID: 7824478)
1. [Erection disorders: efficacy and tolerability after 6 months of intracavernous self-injections of alprostadil. Groupe Français d'Etude de l'Alprostadil].
Giuliano F; Blanchet P; Banzet O; Lancrenon S; Benoît G; Jardin A
Presse Med; 1994 Oct; 23(33):1516-21. PubMed ID: 7824478
[TBL] [Abstract][Full Text] [Related]
2. Erectile rehabilitation with intracavernous alprostadil after radical prostatectomy: refusal and dropout rates.
Polito M; d'Anzeo G; Conti A; Muzzonigro G
BJU Int; 2012 Dec; 110(11 Pt C):E954-7. PubMed ID: 23078100
[TBL] [Abstract][Full Text] [Related]
3. The long-term safety of alprostadil (prostaglandin-E1) in patients with erectile dysfunction. The European Alprostadil Study Group.
Br J Urol; 1998 Oct; 82(4):538-43. PubMed ID: 9806184
[TBL] [Abstract][Full Text] [Related]
4. Intracavernous self-injection of prostaglandin E1 in the treatment of erectile dysfunction.
Kunelius P; Lukkarinen O
Int J Impot Res; 1999 Feb; 11(1):21-4. PubMed ID: 10098949
[TBL] [Abstract][Full Text] [Related]
5. Intracavernous Alprostadil Alfadex--an effective and well tolerated treatment for erectile dysfunction. Results of a long-term European study.
Porst H; Buvat J; Meuleman E; Michal V; Wagner G
Int J Impot Res; 1998 Dec; 10(4):225-31. PubMed ID: 9884918
[TBL] [Abstract][Full Text] [Related]
6. Intracavernous injection of prostaglandin E1 for the treatment of erectile impotence.
Ishii N; Watanabe H; Irisawa C; Kikuchi Y; Kubota Y; Kawamura S; Suzuki K; Chiba R; Tokiwa M; Shirai M
J Urol; 1989 Feb; 141(2):323-5. PubMed ID: 2913354
[TBL] [Abstract][Full Text] [Related]
7. [Retrospective study on the incidence and cause of drop-out during intracavernous pharmaco-prosthesis therapy].
Giammusso B; Motta M
Arch Ital Urol Androl; 2002 Mar; 74(1):27-31. PubMed ID: 12053447
[TBL] [Abstract][Full Text] [Related]
8. Intracavernous injections of prostaglandin E1 for erectile dysfunction: patient satisfaction and quality of sex life on long-term treatment.
Alexandre B; Lemaire A; Desvaux P; Amar E
J Sex Med; 2007 Mar; 4(2):426-31. PubMed ID: 17367438
[TBL] [Abstract][Full Text] [Related]
9. [Intracavernous auto-injection of prostaglandin E1 for diagnosis and treatment of erectile dysfunction].
Arielly J; Weinberg D; Eliraz A; Adam M; el-Hanani BI; Eisenkraft S
Harefuah; 1994 Apr; 126(7):369-73, 426. PubMed ID: 8200581
[TBL] [Abstract][Full Text] [Related]
10. Long-term efficacy and safety of self-intracavernous injection of prostaglandin E1 for treatment of erectile dysfunction in China.
He L; Wen J; Jiang X; Chen H; Tang Y
Andrologia; 2011 Jun; 43(3):208-12. PubMed ID: 21486416
[TBL] [Abstract][Full Text] [Related]
11. Intracavernous self-injection of prostaglandin E1 in the therapy of erectile dysfunction.
Porst H; van Ahlen H; Block T; Halbig W; Hautmann R; Löchner-Ernst D; Rudnick J; Staehler G; Weber HM; Weidner W
Vasa Suppl; 1989; 28():50-6. PubMed ID: 2609244
[TBL] [Abstract][Full Text] [Related]
12. [Dose adaptation during training of intracavernous self-injections of prostaglandin E1].
Staerman F; Veilhan LA; Guiraud P; Coeurdacier P; Cipolla B; Lobel B
Prog Urol; 1996; 6(4):564-8. PubMed ID: 8924934
[TBL] [Abstract][Full Text] [Related]
13. [Prostaglandin E1 in erectile dysfunction].
Porst H
Urologe A; 1989 Mar; 28(2):94-8. PubMed ID: 2655258
[TBL] [Abstract][Full Text] [Related]
14. Nocturnal penile tumescence activity unchanged after long-term intracavernous injection therapy.
Maniam P; Seftel AD; Corty EW; Rutchik SD; Hampel N; Althof SE
J Urol; 2001 Mar; 165(3):830-2; discussion 832-3. PubMed ID: 11176480
[TBL] [Abstract][Full Text] [Related]
15. Efficacy and safety of intracavernosal alprostadil in men with erectile dysfunction. The Alprostadil Study Group.
Linet OI; Ogrinc FG
N Engl J Med; 1996 Apr; 334(14):873-7. PubMed ID: 8596569
[TBL] [Abstract][Full Text] [Related]
16. Sexual rehabilitation and penile pain associated with intracavernous alprostadil after radical prostatectomy.
Yiou R; Cunin P; de la Taille A; Salomon L; Binhas M; Lingombet O; Paul M; Abbou C
J Sex Med; 2011 Feb; 8(2):575-82. PubMed ID: 20807323
[TBL] [Abstract][Full Text] [Related]
17. Return of spontaneous erection during long-term intracavernosal alprostadil (Caverject) treatment.
Brock G; Tu LM; Linet OI
Urology; 2001 Mar; 57(3):536-41. PubMed ID: 11248634
[TBL] [Abstract][Full Text] [Related]
18. Intracavernous injection of prostaglandin E1 in spinal cord injured patients with erectile dysfunction. A preliminary report.
Tang SF; Chu NK; Wong MK
Paraplegia; 1995 Dec; 33(12):731-3. PubMed ID: 8927414
[TBL] [Abstract][Full Text] [Related]
19. [Intracavernous injections of prostaglandin E1 in the treatment of erection disorders].
Beretta G; Zanollo A; Portalupi W
Arch Ital Urol Nefrol Androl; 1991 Dec; 63(4):481-5. PubMed ID: 1838836
[TBL] [Abstract][Full Text] [Related]
20. [Intraurethrally applicated alprostadil for the treatment of organic erectile dysfunction in practice: a multicenter clinical monitoring study (noninterventional investigation)].
Potempal AJ; Potempa DM; Görlich HD; Stolpmann RM
Arzneimittelforschung; 2007; 57(6):299-308. PubMed ID: 17688074
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
